We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPMD icon
551
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
$201K ﹤0.01%
+6,300
New +$194K
CSWC icon
552
Capital Southwest
CSWC
$1.46B
$183K ﹤0.01%
10,664
JPS
553
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$181K ﹤0.01%
17,339
HPE icon
554
Hewlett Packard
HPE
$63.2B
$180K ﹤0.01%
12,207
-3,528
-22% -$48.1K
BBD icon
555
Banco Bradesco
BBD
$38.1B
$174K ﹤0.01%
27,661
TWNK
556
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$150K ﹤0.01%
+10,947
New +$158K
PMM
557
Franklin Managed Municipal Income Trust
PMM
$275M
$144K ﹤0.01%
19,092
MTVA
558
MetaVia Inc
MTVA
$7.64M
0
MRO
559
DELISTED
Marathon Oil Corporation
MRO
$138K ﹤0.01%
10,196
ICAD
560
DELISTED
iCAD Inc
ICAD
$133K ﹤0.01%
+30,000
New +$115K
NAGE
561
Niagen Bioscience
NAGE
$256M
$129K ﹤0.01%
30,000
-8,834
-23% -$32.3K
DNP icon
562
DNP Select Income Fund
DNP
$4.18B
$115K ﹤0.01%
10,000
MFM
563
Aberdeen Municipal Income Fund
MFM
$222M
$100K ﹤0.01%
13,906
WLL
564
DELISTED
Whiting Petroleum Corporation
WLL
$95K ﹤0.01%
58
-6
-9% -$8.82K
HGT
565
DELISTED
Hugoton Royalty Trust
HGT
$45K ﹤0.01%
24,300
-300
-1% -$533
ASXC
566
DELISTED
Asensus Surgical, Inc.
ASXC
$19K ﹤0.01%
1,000
-346
-26% -$4.03K
OPGN
567
DELISTED
OpGen, Inc
OPGN
0
BKD icon
568
Brookdale Senior Living
BKD
$3.62B
-275,001
Closed -$4.04M
IGSB icon
569
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
-4,520
Closed -$238K
JWN
570
DELISTED
Nordstrom
JWN
-4,224
Closed -$202K
MTX icon
571
Minerals Technologies
MTX
$2.31B
-15,496
Closed -$1.13M
PCN
572
PIMCO Corporate & Income Strategy Fund
PCN
$870M
-10,250
Closed -$178K
PRAA icon
573
PRA Group
PRAA
$648M
-16,847
Closed -$639K
SCL icon
574
Stepan Co
SCL
$1.31B
-3,000
Closed -$261K
SNCR
575
DELISTED
Synchronoss Technologies
SNCR
-12,443
Closed -$1.84M

Similar funds

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.